BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Lung cancer
,
Lymphocyte
,
Holistic medicine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PDGFRs
Summary
General Info
Curated Studies
Most Correlated Studies
Livers 72hr post partial hepatectomy with hepatic stellate cell-specific b-PDGFR knockout
Bladder smooth muscle cells treated with platelet-derived growth factor (PDGF-BB) for 0, 4 or 24hr
Expression data from PDGF-treated SH-SY5Y cells
Hepatic stellate cells from wildtype or PDGFRb knockout mice treated with PDGF-B
Liver stellate cells with GIPC1 shRNA knockdown treated with PDGFb
Explore Curated Studies Results
Literature
Most Relevant Literature
MPN-521 Somatic Mutational Landscape and Clinical Response to Upfront Targeted Tyrosine Kinase Inhib…
Detection of FIP1L1-PDGFRA fusion gene-positive cells in the skin lesion of a patient with hypereosi…
Suppressive stroma-immune prognostic signature impedes immunotherapy in ovarian cancer and can be re…
Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement.
Novel ANKRD26 and PDGFRB gene mutations in pediatric case of non-Langerhans cell histiocytosis: Case…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study.
Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST
Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations
Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glio…
Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ